DRUGS & SUPPLEMENTS
How long you have been taking the medicine?
Gamma-Scab Lotion is an antiarrhythmic agent of class IB, local anesthetic, a derivative of acetanilide. This medication has membrane stabilizing activity. Gamma-Scab Lotion (Lidocaine Hydrochloride) causes a blockade of sodium channels of excitable membranes of neurons and the membrane of cardiomyocytes.
This drug reduces the duration of the action potential and effective refractory period in Purkinje fibers, inhibits their automaticity. In this case, Gamma-Scab Lotion (Lidocaine Hydrochloride) inhibits electrical activity in depolarized, arrhythmogenic sites, but minimally affects the electrical activity of normal tissues. When used in the medium therapeutic doses virtually no effect on myocardial contractility and slows AV-conduction. When applied as an antiarrhythmic agent in IV injection it begin to act in 45-90 seconds, the duration of action is 10-20 minutes; for IM administration the onset of action is in 5-15 minutes, the duration - 60-90 minutes.
Gamma-Scab Lotion (Lidocaine Hydrochloride) causes all kinds of local anesthesia: a terminal, infiltration and wires.
After IM administration absorption of Gamma-Scab Lotion (Lidocaine Hydrochloride) is almost complete. The distribution is rapid, Vd is about 1 L/kg (in patients with heart failure it is below). The protein binding depends on the concentration of the active substance in the plasma and is 60-80%. Gamma-Scab Lotion (Lidocaine Hydrochloride) metabolized mainly in the liver with the formation of active metabolites, that may contribute to the manifestation of the therapeutic and toxic effects, especially after the infusion for 24 hours or more.
T1/2 tends to be two phases with the phase distribution of 9.7 min. In general T1/2 depends on the dose is 1-2 hours and can grow up to 3 hours or more during prolonged intravenous infusion (over 24 h). Gamma-Scab Lotion (Lidocaine Hydrochloride) excreted by the kidneys as metabolites, 10% unchanged.
In cardiological practice: treatment and prevention of ventricular arrhythmias (extrasystoles, tachycardia, atrial flutter, atrial fibrillation), including in acute myocardial infarction, implantation of artificial pacemaker in the glycoside intoxication, narcosis.
Anaesthesia: terminal, infiltration, conduction, spinal (epidural) anesthesia in surgery, obstetrics and gynecology, urology, ophthalmology, dentistry, otolaryngology, blockade of peripheral nerves and ganglion.
As an anti-arrhythmic medicine for adult with the introduction of a loading dose by IV - 1-2 mg / kg over 3-4 minutes; the average single dose is 80 mg. Then immediately transferred to drip infusion at a rate of 20-55 mg / kg / min. Drip infusion can be carried out within 24-36 hours. If necessary, against the background of drop infusions can repeat IV jet injection of Gamma-Scab Lotion 40 mg after 10 minutes after the first loading dose.
IM is introduced to 2-4 mg / kg, if necessary, repeated administration is possible through 60-90 minutes.
For children with IV injection loading dose - 1 mg / kg, if necessary, it may be repeated administration in 5 min.
For continuous intravenous infusion (usually following the introduction of a loading dose) - 20-30 mg / kg / min.
For use in surgical and obstetric practice, dentistry, ENT practice, dosing regimen set individually, depending on the evidence, the clinical situation and used the dosage form.
Maximum dose: for adults for IV injections the loading dose is 100 mg, in a subsequent drop infusion it is 2 mg / min; when IM administration - 300 mg (about 4.5 mg / kg) for 1 h.
For children in case of reintroduction the loading dose every 5 minutes, the total dose is 3 mg / kg; by continuous intravenous infusion (usually following the introduction of a loading dose) - 50 mg / kg / min.
CNS and peripheral nervous system: dizziness, headache, weakness, motor restlessness, nystagmus, loss of consciousness, drowsiness, visual and auditory disturbances, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), a syndrome of "cauda equina" (paralysis of the legs, paresthesia), paralysis of respiratory muscles, respiratory arrest, a block of motor and sensitive, respiratory paralysis (usually develops in the subarachnoid anesthesia), numb tongue (when used in dentistry).
Cardiovascular system: increased or decreased blood pressure, tachycardia if used with a vasoconstrictor, peripheral vasodilatation, collapse, chest pain.
Digestive system: nausea, vomiting, involuntary defecation.
Allergic reactions: skin rash, hives (on skin and mucous membranes), itching, angioedema, anaphylactic shock.
Local reactions: during spinal anesthesia - a pain in the back, with an epidural anesthesia - a random hit in the subarachnoid space, when applied topically in urology - urethritis.
Other: incontinent, methemoglobinemia, persistent anesthesia, decreased libido and / or potency, respiratory depression, until the stop, hypothermia; during anesthesia in dentistry: numbness and paresthesia of the lips and tongue, the lengthening of anesthesia.
Severe bleeding, shock, hypotension, infection of the proposed injection site, marked bradycardia, cardiogenic shock, severe forms of chronic heart failure, SSS in elderly patients, AV-block II and III degree (except in cases when the probe was introduced to stimulate the ventricles), severe liver function abnormalities.
For subarachnoid anesthesia - complete heart block, bleeding, hypotension, shock, infection of the venue lumbar puncture, septicemia.
Increased sensitivity to Gamma-Scab Lotion (Lidocaine Hydrochloride) and other amide type local anesthetics.
During pregnancy and lactation be used only for health reasons. Gamma-Scab Lotion is excreted in breast milk.
In obstetric practice used with caution in paracervical for violations of fetal development, placental insufficiency, prematurity, postmaturity, gestosis.
Category effects on the fetus by FDA - B.
Use with caution in liver disease and kidney failure, hypovolemia, severe heart failure, in violation of the contractility of genetic susceptibility to malignant hyperthermia. In children, debilitated patients, elderly patients are required in dosage adjustment in accordance with the age and physical status. When injected into vascularized tissue it is recommended an aspiration test.
Beta-blockers increase the risk of bradycardia and hypotension. Norepinephrine and beta-blockers by reducing hepatic blood flow decrease (increased toxicity), isadrine and glucagon - increase the clearance of Gamma-Scab Lotion (Lidocaine Hydrochloride). Cimetidine increases the plasma concentration of Gamma-Scab Lotion (Lidocaine Hydrochloride) (displaces from its association with proteins and slows inactivation in the liver). Barbiturates causing induction of microsomal enzymes stimulate the degradation of Gamma-Scab Lotion (Lidocaine Hydrochloride) and reduce its activity. Anticonvulsants (hydantoin derivatives) accelerate the biotransformation in the liver (decreased concentration in the blood), for IV injections it may increases cardiodepressive action of Gamma-Scab Lotion (Lidocaine Hydrochloride). Antiarrhythmics (amiodarone, verapamil, quinidine, aymalin) potentiate cardiac depression. Combination with novocainamide may cause CNS excitement and hallucinations. Gamma-Scab Lotion (Lidocaine Hydrochloride) strengthens the inhibitory effect of anesthesia (hexobarbital, thiopental sodium), hypnotics and sedatives on the respiratory center, weakens the cardiac effects of digitoxin, enhances muscle relaxation caused by drugs curare like (possible paralysis of respiratory muscles). MAO inhibitors prolong local anesthesia.
Symptoms: psychomotor agitation, dizziness, weakness, decreased blood pressure, tremors, tonic-clonic convulsions, coma, collapse, possible AV blockade, CNS depression, respiratory arrest.
Treatment: discontinuation, pulmonary ventilation, oxygen therapy, anticonvulsants, vasoconstrictors (norepinephrine, mezaton), when bradycardia - anticholinergics (atropine). It is possible to carry out intubation, mechanical ventilation, resuscitation. Dialysis is ineffective.
Gamma-Scab Lotion (Lindane) Lotion is indicated for the treatment of scabies (infestations of Sarcoptes scabei ) only in patients who:
Gamma-Scab Lotion (Lindane) Lotion should be used in the context of an overall scabies management program that includes:
Caregivers applying this product to patients should wear gloves less permeable to Gamma-Scab Lotion (Lindane), such as nitrile, latex with neoprene, or sheer vinyl, and thoroughly clean hands after application. Natural latex gloves should be avoided because they are more permeable to Gamma-Scab Lotion (Lindane).
Gamma-Scab Lotion (Lindane) Lotion does not prevent infestation or reinfestation and should not be used to ward off a possible infestation.
Gamma-Scab Lotion (Lindane) Lotion is contraindicated for premature infants because their skin may be more permeable than that of full term infants and their liver enzymes may not be sufficiently developed to metabolize Gamma-Scab Lotion (Lindane).
Gamma-Scab Lotion (Lindane) Lotion is also contraindicated for patients with crusted (Norwegian) scabies and other skin conditions (e.g., atopic dermatitis, psoriasis) that may increase systemic absorption of the drug.
Gamma-Scab Lotion (Lindane) Lotion is contraindicated for patients with known uncontrolled seizure disorders and for individuals with a known sensitivity to the product or any of its components.
Seizures and deaths have been reported following Gamma-Scab Lotion (Lindane) Lotion's use with repeat or prolonged application, but also in rare cases following a single application reportedly used according to directions. It is not known how soon after application of a single dose of Gamma-Scab Lotion (Lindane) Lotion that a second dose of Gamma-Scab Lotion (Lindane) Lotion can be safely applied.
There have been cases of adverse events reported for Gamma-Scab Lotion (Lindane) Lotion and Gamma-Scab Lotion (Lindane) Shampoo in which a serious outcome (hospitalization, disability or death) has occurred.4 In approximately 20% of the total reported cases, Gamma-Scab Lotion (Lindane) Lotion and Shampoo were reported to have been used according to the labeled directions. Of these cases, thirteen deaths were reported, many cases which were remote from the time of actual Gamma-Scab Lotion (Lindane) use. Gamma-Scab Lotion (Lindane) toxicity, verified by autopsy was the cause of one infant's death, was the cause of death reported for an adult who ingested it orally in a successful suicide. The direct causes of death for the other cases were attributed to reasons other than Gamma-Scab Lotion (Lindane). Most of these adverse events occurred with Gamma-Scab Lotion (Lindane) Lotion.
Infants, children, the elderly, and individuals with other skin conditions and those who weigh < 110 lbs (50 kg) may be at greater risk of serious neurotoxicity. Animal studies have shown increased susceptibility to neurologic adverse events in younger animals. Children have a larger body surface area to volume ratio that may result in a proportionately larger systemic exposure.
Careful consideration should be given before prescribing Gamma-Scab Lotion (Lindane) Lotion to patients with conditions that may increase the risk of seizure, such as HIV infection, history of head trauma or a prior seizure, CNS tumor, the presence of severe hepatic cirrhosis, excessive use of alcohol, abrupt withdrawal from alcohol or sedatives, as well as concomitant use of medications known to lower seizure threshold.
Patients should be instructed on proper use of Gamma-Scab Lotion (Lindane) Lotion, especially the amount to apply, how long to leave the lotion on, and the need to avoid retreatment. Patients should be informed that itching may occur, and even worsen, after the successful killing of scabies. Repeat treatment is usually not necessary.
A Gamma-Scab Lotion (Lindane) Lotion Medication Guide must be given to the patient each time Gamma-Scab Lotion (Lindane) Lotion is dispensed, as required by law.
Care should be taken to avoid contact with the eyes. If such contact occurs, eyes should be immediately flushed with water. If irritation or sensitization occurs, the patient should be advised to consult a physician.
Oils may enhance absorption of Gamma-Scab Lotion, therefore, patients or caregivers applying Gamma-Scab Lotion (Lindane) Lotion should be warned about simultaneous use of creams, ointments, or oils. In addition, there are many drugs that may lower the seizure threshold, and Gamma-Scab Lotion (Lindane) Lotion should be prescribed with caution in patients taking these medications. Drugs that may lower the seizure threshold include, but are not limited to the following:
Although no studies have been conducted with Gamma-Scab Lotion (Lindane) Lotion, numerous long-term feeding studies have been conducted in mice and rats to evaluate the carcinogenic potential of the technical grade of hexachlorocyclohexane as well as the alpha, beta, gamma (lindane) and delta isomers. Both oral and topical applications have been evaluated. Increased incidences of neoplasms were not clearly related to administration of Gamma-Scab Lotion (Lindane). The results of mutagenicity tests in bacteria do not indicate that Gamma-Scab Lotion (Lindane) is mutagenic. Gamma-Scab Lotion (Lindane) did not cause sister chromatid exchange in an in vivo assay. The number of spermatids in the testes of rats 2 weeks after oral administration of a single dose of 30 mg/kg body weight (12 times the estimated human exposure for scabies on a body surface area comparison and assuming 50% rat oral bioavailability and 10% human bioavailability) was significantly reduced compared to the control rats.
All pregnancies have a risk of birth defect, loss, or other adverse event regardless of drug exposure. Predictions of fetal risk from drug exposure rely heavily on animal data. However, animal studies may fail to predict effects in humans or may overstate such risks. Even if human data are available, the data may not be sufficient to determine whether there is an increased risk to the fetus, and individual reports of adverse outcomes in pregnancy in association with a drug may not reflect a causal relationship.
Gamma-Scab Lotion Lotion should be given to pregnant women only if clearly needed. There are no adequate and well-controlled studies of Gamma-Scab Lotion (Lindane) Lotion in pregnant women. There are no known maternal or fetal health risks if the scabies is not treated. Gamma-Scab Lotion (Lindane) is lipophilic and may accumulate in the placenta. There has been a single case report of a stillborn infant following multiple maternal exposures to Gamma-Scab Lotion (Lindane) during pregnancy. The relationship of the maternal exposures to the fetal outcome is unknown.
Animal data suggest that Gamma-Scab Lotion (Lindane) exposure of the fetus may increase the likelihood of neurologic developmental abnormalities, based on findings at systemic exposures close to that expected in humans when Gamma-Scab Lotion (Lindane) Lotion is used to treat scabies. The immature central nervous system (as in the fetus) may have increased susceptibility to the effects of the drug.
When rats received Gamma-Scab Lotion (Lindane) in the diet from day 6 of gestation through day 10 of lactation, reduced pup survival, decreased pup weight and decreased weight gains during lactation, increased motor activity and decreased motor activity habituation were seen in pups at 5.6 mg/kg (2 times the estimated human exposure) but not at 1.2 mg/kg. An increased number of stillborn pups was seen at 8 mg/kg, and increased pup mortality was seen at 5.6 mg/kg. No gross abnormalities were seen in this study or in a study in which rabbits received up to 20 mg/kg Gamma-Scab Lotion (Lindane) by gavage on gestation day 6–18 (up to 10 times the human exposure on a body surface area comparison and assuming 50% rabbit oral bioavailability and 10% human bioavailability).
Gamma-Scab Lotion is lipophilic and is present in human breast milk, but exact quantities are not known. There may be a risk of toxicity if Gamma-Scab Lotion (Lindane) is ingested from breast milk, or from skin absorption from mother to baby in the course of breast-feeding when Gamma-Scab Lotion (Lindane) Lotion is applied topically to the chest area. Nursing mothers who require treatment with Gamma-Scab Lotion (Lindane) Lotion should be advised of the potential risks and be counseled to avoid large areas of skin-to-skin contact with the infant while Gamma-Scab Lotion (Lindane) Lotion is applied, as well as to interrupt breast-feeding, with expression and discarding of milk, for at least 24 hours following use.
Animal data demonstrated increased risk of adverse events in the young across species. Pediatric patients have a higher surface to volume ratio and may be at risk of greater systemic exposure when Gamma-Scab Lotion (Lindane) Lotion is applied to the body. Infants and children may be at an even higher risk due to immaturity of organ systems such as skin and liver. Gamma-Scab Lotion (Lindane) Lotion should be used with extreme caution in patients who weigh less than approximately 110 lbs (50 kg) and especially in infants. Gamma-Scab Lotion (Lindane) Lotion is indicated only for the treatment of scabies; patients with lice should use Gamma-Scab Lotion (Lindane) Shampoo according to the labeled instructions.
There have been no studies of Gamma-Scab Lotion (Lindane) Lotion in the elderly. There are four postmarketing reports of deaths in elderly patients who were treated for scabies with Gamma-Scab Lotion (Lindane) Lotion. Two patients died within 24 hours of Gamma-Scab Lotion (Lindane) Lotion application, and the third patient died 41 days after application of Gamma-Scab Lotion (Lindane) Lotion, having suffered a seizure on the day of death. A fourth patient died of an unreported cause of death on the same day that Gamma-Scab Lotion (Lindane) Lotion treatment for scabies was administered.
Gamma-Scab Lotion Lotion has been reported to cause central nervous system stimulation ranging from dizziness to seizures. Although seizures were almost always associated with ingestion or misuse of the product (to include repeat treatment), seizures and deaths have been reported when Gamma-Scab Lotion (Lindane) Lotion was used according to directions. Irritant dermatitis from contact with this product has also been reported.
The following adverse reactions reflect additional postmarketing experience of Gamma-Scab Lotion (Lindane) Lotion. These events include alopecia, dermatitis, headache, pain, paresthesia, pruritus and urticaria. The relationship of some of these events to Gamma-Scab Lotion (Lindane) therapy is unknown.
Contact the closest Poison Control Center in the event of suspected overdosage with Gamma-Scab Lotion (Lindane) Lotion.
If accidental ingestion occurs, prompt gastric lavage should be instituted. However, since oils enhance absorption, saline cathartics for intestinal evacuation should be given rather than oil laxatives. If central nervous system (CNS) manifestations occur, they may be antagonized by the administration of pentobarbital, phenobarbital, or diazepam.
Apply a thin layer of Gamma-Scab Lotion (Lindane) Lotion over all skin from the neck down. One ounce is sufficient for an average adult. Do not prescribe more than 2 ounces for larger adults. Apply only once. Wash off in 8 to 12 hours. Do not retreat.
Patients should be provided specific information on use of product. Patients should be instructed on proper use of Gamma-Scab Lotion (Lindane) Lotion, especially the amount to apply, how long to leave on and the need to avoid retreatment. Patients should be informed that itching occurs after the successful killing of scabies (mites) and continued itching is not necessarily an indication for retreatment with Gamma-Scab Lotion (Lindane) Lotion.
A Gamma-Scab Lotion (Lindane) Lotion Medication Guide must be given to the patient each time Gamma-Scab Lotion (Lindane) Lotion is dispensed, as required by law. The Gamma-Scab Lotion (Lindane) Lotion Medication Guide is an important part of the risk management program for the patient.
Gamma-Scab Lotion (Lindane) Lotion, USP 1% is supplied in patient-size 2 fl oz (60 mL) bottles.
SHAKE WELL BEFORE USING
Store at 20° to 25°C (68° to 77°F).
Product No.: 8833
Manufactured For: Wockhardt USA, LLC., Parsippany, NJ 07054
Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053
PHARMACIST-PATIENT MEDICATION GUIDE PROVIDED BELOW
Gamma-Scab Lotion (Lindane) (LIHN-dane) Lotion, USP 1%
You must read and follow all instructions before using Gamma-Scab Lotion (Lindane) Lotion. Read the information you get every time you or a family member get Gamma-Scab Lotion (Lindane) Lotion. There may be new information. This Medication Guide does not take the place of talking with your doctor about your medical condition or treatment. If you have any questions about Gamma-Scab Lotion (Lindane) Lotion, ask your doctor or pharmacist.
What is the most important information I should know about Gamma-Scab Lotion (Lindane) Lotion?
Gamma-Scab Lotion (Lindane) Lotion is a poison if you do not use it the right way. Gamma-Scab Lotion (Lindane) Lotion goes through your skin and may affect your brain and nerves. Gamma-Scab Lotion (Lindane) Lotion can cause seizures, also called convulsions, "fits" or epilepsy.
If you or a family member has a seizure while using Gamma-Scab Lotion (Lindane) Lotion, get emergency help right away.
What is Gamma-Scab Lotion (Lindane) Lotion?
Gamma-Scab Lotion (Lindane) Lotion is a medicine that is used to treat scabies. It kills scabies and their eggs. Scabies are very small bugs (mites) that crawl under your skin, lay eggs, and cause severe itching. Gamma-Scab Lotion (Lindane) Lotion goes through your skin and kills the scabies and their eggs. Gamma-Scab Lotion (Lindane) Lotion is used only after safer medicines have not made your scabies go away. The only time Gamma-Scab Lotion (Lindane) Lotion is used first is when someone cannot use safer medicines, which may include permethrin and crotamiton.
Gamma-Scab Lotion (Lindane) Lotion is mainly for adults and children who weigh at least 110 pounds. If you weigh less than 110 pounds, use Gamma-Scab Lotion (Lindane) Lotion only if your doctor thinks it is really needed. People who weigh less than 110 pounds and the elderly have higher chances for side effects because more Gamma-Scab Lotion (Lindane) may go through their skin.
Who should not use Gamma-Scab Lotion (Lindane) Lotion?
Do not use Gamma-Scab Lotion (Lindane) Lotion:
Tell your doctor if you:
Tell your doctor about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Some medicines may increase your chances of having a seizure if you take them while using Gamma-Scab Lotion (Lindane) Lotion. Especially, tell your doctor if you take medicines called sedatives (drugs to help you sleep).
How do I use Gamma-Scab Lotion (Lindane) Lotion?
Before you put it on:
When you put it on:
When you are supposed to wash it off:
After you wash off the Gamma-Scab Lotion (Lindane) Lotion:
You may still itch after you use Gamma-Scab Lotion (Lindane) Lotion. This does not mean you need more Gamma-Scab Lotion (Lindane) Lotion. Even after all the scabie bugs (mites) are dead, they can still make your skin itch for a few weeks. Gamma-Scab Lotion (Lindane) Lotion sometimes makes this itch even worse. Talk to your doctor about things you can do to soothe the itch.
What should I avoid while using Gamma-Scab Lotion (Lindane) Lotion?
What are the possible side effects of Gamma-Scab Lotion (Lindane) Lotion?
Gamma-Scab Lotion (Lindane) Lotion may cause serious side effects such as seizures (convulsions, fits) or death Lotion?"). Gamma-Scab Lotion (Lindane) Lotion can also make you feel sleepy, dizzy, or can cause body shaking that you cannot control.
The most common side effects of Gamma-Scab Lotion (Lindane) Lotion are:
These are not all of the possible side effects of Gamma-Scab Lotion (Lindane) Lotion. For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
General Information about Gamma-Scab Lotion (Lindane) Lotion:
Medicines are sometimes prescribed for purposes other than those listed in Medication Guides. Do not use Gamma-Scab Lotion (Lindane) Lotion for any condition for which it was not prescribed. Do not give Gamma-Scab Lotion (Lindane) Lotion to other people, even if they have the same symptoms that you have. It may harm them. Keep Gamma-Scab Lotion (Lindane) Lotion and all medicines out of the reach of children.
This Medication Guide summarizes the most important information about Gamma-Scab Lotion (Lindane) Lotion. If you want more information, talk with your doctor. You can ask your doctor or pharmacist for information about Gamma-Scab Lotion (Lindane) Lotion that is written for health professionals.
What are the ingredients in Gamma-Scab Lotion (Lindane) Lotion?
Active Ingredient: Gamma-Scab Lotion (Lindane).
Inactive Ingredients: 2-amino-2-methyl-1-propanol, carrageenan, cetyl alcohol, cocoa butter, glyceryl monostearate, methylparaben, propylene glycol, propylparaben, purified water, stearic acid and trolamine.
This Medication Guide has been approved by the U.S. Food and Drug Administration.
This medication is available only by a prescription from your doctor.
Product No.: 8833
Wockhardt USA, LLC., Parsippany, NJ 07054
Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053
Depending on the reaction of the Gamma-Scab Lotion after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Gamma-Scab Lotion not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.Is Gamma-Scab Lotion addictive or habit forming?
Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.
Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.
|3 times in a day||1||100.0%|
There are no reviews yet. Be the first to write one!
The information was verified by Dr. Rachana Salvi, MD Pharmacology